Randomized controlled trial comparing radiotherapy plus /- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG0401

被引:0
|
作者
Yokomizo, A. [1 ]
Satoh, T. [2 ]
Hashine, K. [3 ]
Inoue, T. [4 ]
Fujimoto, K. [5 ]
Egawa, S. [6 ]
Habuchi, T. [7 ]
Kawashima, K. [8 ]
Ishizuka, O. [9 ]
Shinohara, N. [10 ]
Sugimoto, M. [11 ]
Yoshino, Y. [12 ]
Wakabayashi, M. [13 ]
Nihei, K. [14 ]
Fukuda, H. [13 ]
Tobisu, K-I. [15 ]
Kakehi, Y.
Naito, S. [1 ]
机构
[1] Harasanshin Hosp, Urol, Fukuoka, Japan
[2] Kitasato Univ, Urol, Sch Med, Sagamihara, Kanagawa, Japan
[3] Natl Hosp Org, Urol, Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[4] Kyoto Univ, Urol, Kyoto, Japan
[5] Nara Med Univ, Urol, Nara, Japan
[6] Jikei Univ Hosp, Urol, Tokyo, Japan
[7] Akita Univ, Urol, Grad Sch Med, Akita, Japan
[8] Tochigi Canc Ctr, Urol, Utsunomiya, Tochigi, Japan
[9] Shinshu Univ, Urol, Sch Med, Matsumoto, Japan
[10] Hokkaido Univ Hosp, Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan
[11] Kagawa Univ, Urol, Fac Med, Takamatsu, Kagawa, Japan
[12] Nagoya Univ, Urol, Grad Sch Med, Nagoya, Aichi, Japan
[13] Natl Canc Ctr, JCOG Data Ctr, Operat Off, Tokyo, Japan
[14] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Radiat Oncol, Tokyo, Japan
[15] Komagome Hosp, Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
788PD
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG1407)
    Fukutomi, A.
    Mizusawa, J.
    Katayama, H.
    Okusaka, T.
    Ito, T.
    Okano, N.
    Mizuno, N.
    Ikeda, M.
    Ueno, M.
    Shioji, K.
    Ozaka, M.
    Shimizu, S.
    Sakamoto, Y.
    Kondo, S.
    Kawabe, K.
    Eba, J.
    Ishii, H.
    Fukuda, H.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).
    Ueno, Makoto
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Katayama, Hiroshi
    Ikeda, Masafumi
    Ozaka, Masato
    Sugimori, Kazuya
    Fukutomi, Akira
    Hara, Hiroki
    Mizuno, Nobumasa
    Yanagimoto, Hiroaki
    Sano, Keiji
    Tobimatsu, Kazutoshi
    Yane, Kei
    Nakamori, Shoji
    Sata, Naohiro
    Yukisawa, Seigo
    Ishii, Hiroshi
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)
    Nakachi, Kohei
    Konishi, Masaru
    Ikeda, Masafumi
    Mizusawa, Junki
    Eba, Junko
    Okusaka, Takuji
    Ishii, Hiroshi
    Fukuda, Haruhiko
    Furuse, Junji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (04) : 392 - 395
  • [24] Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
    Lu, Yen-Shen
    Im, Seock-Ah
    Colleoni, Marco
    Franke, Fabio
    Bardia, Aditya
    Cardoso, Fatima
    Harbeck, Nadia
    Hurvitz, Sara
    Chow, Louis
    Sohn, Joohyuk
    Lee, Keun Seok
    Campos-Gomez, Saul
    Vazquez, Rafael Villanueva
    Jung, Kyung Hae
    Babu, K. Govind
    Wheatley-Price, Paul
    De Laurentiis, Michelino
    Im, Young-Hyuck
    Kuemmel, Sherko
    El-Saghir, Nagi
    O'Regan, Ruth
    Gasch, Claudia
    Solovieff, Nadia
    Wang, Craig
    Wang, Yongyu
    Chakravartty, Arunava
    Ji, Yan
    Tripathy, Debu
    CLINICAL CANCER RESEARCH, 2022, 28 (05) : 851 - 859
  • [25] Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207
    Tsukada, Hiroko
    Yokoyama, Akira
    Goto, Koichi
    Shinkai, Tetsu
    Harada, Masao
    Ando, Masahiko
    Shibata, Taro
    Ohe, Yuichiro
    Tamura, Tomohide
    Saijo, Nagahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 88 - 95
  • [26] Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
    N Katsumata
    H Yoshikawa
    H Kobayashi
    T Saito
    K Kuzuya
    T Nakanishi
    T Yasugi
    N Yaegashi
    H Yokota
    S Kodama
    T Mizunoe
    M Hiura
    T Kasamatsu
    T Shibata
    T Kamura
    British Journal of Cancer, 2013, 108 : 1957 - 1963
  • [27] Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
    Katsumata, N.
    Yoshikawa, H.
    Kobayashi, H.
    Saito, T.
    Kuzuya, K.
    Nakanishi, T.
    Yasugi, T.
    Yaegashi, N.
    Yokota, H.
    Kodama, S.
    Mizunoe, T.
    Hiura, M.
    Kasamatsu, T.
    Shibata, T.
    Kamura, T.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 1957 - 1963
  • [28] A RANDOMIZED PHASE III TRIAL OF PACLITAXEL PLUS CARBOPLATIN (TC) VERSUS PACLITAXEL PLUS CISPLATIN (TP) IN STAGE IVB OR RECURRENT CERVICAL CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0505)
    Kitagawa, R.
    Katsumata, N.
    Shibata, T.
    Nakanishi, T.
    Nishimura, S.
    Nishio, S.
    Takano, M.
    Satoh, T.
    Yokota, H.
    Ochiai, K.
    Kigawa, J.
    Kobayashi, H.
    Kanato, K.
    Yoshikawa, H.
    Kamura, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 126 - 126
  • [29] Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401)
    Tadahiko Shien
    Hiroji Iwata
    Kenjiro Aogi
    Takashi Fukutomi
    Kenichi Inoue
    Takayuki Kinoshita
    Masato Takahashi
    Akira Matsui
    Taro Shibata
    Haruhiko Fukuda
    International Journal of Clinical Oncology, 2014, 19 : 982 - 988
  • [30] A Randomized Controlled Trial Comparing Laparoscopic Surgery with Open Surgery in Palliative Resection of Primary Tumor in Incurable Stage IV Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE Trial)
    Inomata, Masafumi
    Akagi, Tomonori
    Katayama, Hiroshi
    Kimura, Aya
    Mizusawa, Junki
    Etoh, Tsuyoshi
    Yamaguchi, Shigeki
    Ito, Masaaki
    Kinugasa, Yusuke
    Saida, Yoshihisa
    Hasegawa, Hirotoshi
    Ota, Mitsuyoshi
    Kanemitsu, Yukihide
    Shimada, Yasuhiro
    Kitano, Seigo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (11) : 1123 - 1126